The National Association of Chain Drug Stores (NACDS) is joining with California State Senator Scott Wiener (D), the California Chronic Care Coalition and the California Pharmacists Association to urge the enactment of needed pharmacy benefit manager (PBM) reforms in the state. On Monday, September 16, at 10:00 AM PST/1:00 PM EST, Senator Wiener will join pharmacists, patients and physicians at Mission Wellness Pharmacy, located at 2424 Mission Street, San Francisco, CA 94110, to urge California Gov. Gavin Newsom (D) to sign Senate Bill (SB) 966 — pivotal PBM reform legislation that would help rein in the harmful tactics of the PBM middlemen by providing much-needed oversight and transparency. The media event will be live-streamed at the following link: https://www.youtube.com/live/2pSaBAdGMrA Details: WHAT: CA Press Event Calling on Gov. Gavin Newsom to Sign SB 966 WHEN: Monday, September 16, at 10:00 AM PST/1:00 PM EST WHERE: LIVE-STREAM LINK: https://www.youtube.com/live/2pSaBAdGMrA WHO: California State Senator Scott Wiener (D) and his coalition, patients, local pharmacists, patient advocates and others who want urgent action on PBMs | |
| |
NACDS CALLS ON GOV. NEWSOM TO PUT PEOPLE OVER PBMS | |
NACDS President and CEO Steven C. Anderson is asking California Gov. Gavin Newsom (D) to exert his leadership by signing into law SB 966 — and to fuel momentum for needed PBM reforms across the nation: | |
| |
NACDS also joined 25 organizations in a letter to Gov. Gavin Newsom, urging him to sign SB 966 without delay. | |
NACDS fighting for PBM reform in California
The National Association of Chain Drug Stores (NACDS) is joining with California State Senator Scott Wiener (D), the California Chronic Care Coalition and the California Pharmacists Association to urge the enactment of needed pharmacy benefit manager (PBM) reforms in the state.
Related
AAM comments on Amneal's U.S. expansion of end-to-end biosimilars development with their acquisition of Kashiv BioSciences
Adds Chicago research and development facility, New Jersey manufacturing site
Upsher-Smith expands portfolio with launch of Glatiramer Acetate Injection
Latest Addition Advances Upsher-Smith's Strategy to Expand Its Portfolio of Complex Generic Medicines and Broaden Patient Access.
CVS Specialty targets social barriers to care
CVS Specialty is helping patients address food insecurity, housing instability and financial challenges that can make it harder to stay on therapy.
NACHC announces Center for Nutrition and Health to advance food for health initiatives
The Center will strengthen health centers’ capacity to prevent and manage nutrition-related chronic diseases by advancing sustainable F4H initiatives that improve health outcomes and align with value-based care models.
Latest
AAM comments on Amneal's U.S. expansion of end-to-end biosimilars development with their acquisition of Kashiv BioSciences
Adds Chicago research and development facility, New Jersey manufacturing site
NIQ: 58% of consumers say they don't care whether a product is a national brand or private label
New NIQ & World Data Lab report reveals how consumer polarization is redefining value, accelerating private label adoption, and reshaping competition on the shelf.
CRN addresses Consumer Reports prenatal vitamin tests
The association notes that testing method differences and voluntary USP benchmarks should be considered when evaluating prenatal vitamin potency findings.
Upsher-Smith expands portfolio with launch of Glatiramer Acetate Injection
Latest Addition Advances Upsher-Smith's Strategy to Expand Its Portfolio of Complex Generic Medicines and Broaden Patient Access.